L. MARCHIARO, F. MARINO, C. MONTEMAGNI, E. RIVOIRA, P. ROCCA, F. BOGETTO - Vol. 10, March 2004, Issue 1
Testo Immagini Bibliografia Summary Indice
Trattamento farmacologico del disturbo borderline
di personalità
Borderline Personality Disorder: pharmacological treatment
1 Kapfhammer HP, Hippius H. Special feature: pharmacotherapy in personality disorders. J Pers Disorders 1998;12:277-88.
2 Soloff PH. Psychopharmacology of borderline personality disorder. Psychiatr Clin North Am 2000;23:169-92.
3 Tancer ME, Golden RN. A neuropharmacologic test of the tridimensional personality questionnaire in social phobia. Biol Psychiatry 1993;33:48.
4 Gabbard GO. Psychodinamic psychotherapy of borderline personality disorder: a contemporary approach. Bull Menninger Clin 2001;65:41-57.
5 American Psychiatric Association. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 2001;158:1-52.
6 Norden MJ. Fluoxetine in borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:885-93.
7 Cornelius JR, Soloff PH, Perel JM, Ulrich RF. Fluoxetine trial in borderline personality disorder. Psychopharmacol Bull 1990;26:151-4.
8 Markovitz PJ, Calabrese JR, Schulz SC, Melzer HY. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991;148:1064-7.
9 Kavoussi RJ, Liu J, Coccaro EF. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994;55:137-41.
10 Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacology 1995;15:23-9.
11 Markovitz P. Pharmacotherapy of impulsivity, aggression, and related disorders. In: Stein D, Hollander E, eds. Impulsive Aggression and Disorders of Impulse Control. Sussex. England: J. Wiley 1995:263-87.
12 Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 1988;45:111-9.
13 Cornelius JR, Soloff PH, Perel JM, Ulrich RF. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. Am J Psychiatry 1993;150:1843-8.
14 Soloff PH, Cornelius J, George A, Nathan RS, Perel JM, Ulrich RM. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993;50:377-85.
15 Tupin JP, Smith DB, Clanon TL, Kim LI, Nugent A, Groupe A. The long-term use of lithium in aggressive prisoners. Compr Psychiatry 1973;14:311-7.
16 Sheard MH, Marini JL, Bridges CI, Wagner E. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry 1976;133:1409-13.
17 De La Fuente J, Lotstra F. A trial of carbamazepine in borderline personality disorder. Eur Neuropsychopharmacol 1994;4:479-86.
18 Wilcox JA. Divalproex sodium as a treatment for borderline personality disorder. Ann Clin Psychiatry 1995;7:33-7.
19 Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E. An open trial of valproate in borderline personality disorder. J Clin Psychiatry 1995;56:506-10.
20 Kavoussi RJ, Coccaro EF. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder. J Clin Psychiatry 1998;59:676-80.
21 Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry 2001;62:199-203.
22 Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 1997;54:1081-8.
23 Serban G, Siegel S. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am J Psychiatry 1984;141:1455-8.
24 Soloff PH, George A, Nathan RS, Shulz PM, Ulrich RM, Perel JM. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo. Arch Gen Psychiatry 1986;43:691-7.
25 Soloff PH, George A, Nathan S, Shulz PM, Cornelius JR, Herring J. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. J Clin Psychopharmacology 1989;9:238-46.
26 Frankenburg FR, Zanarini MC. Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry 1993;34:402-5.
27 Chengappa KNR, Baker RW, Sirri C. The successful use of clozapine in ameliorating severe self mutilation in a patient with borderline personality disorder. J Pers Disord 1995;9:76-82.
28 Chengappa KN, Ebeling T, Kang JS, Levine J, Parepally H. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry 1999;60:477-84.
29 Benedetti F, Sforzini L, Colombo C, Maffei C, Smeraldi E. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 1998;59:103-7.
30 Schulz SC, Camlin KL, Berry SA, Jesberger JA. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biol Psychiatry 1999;46:1429-35.
31 Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psichiatry 2001;62:849-54.
32 Szigethy EM, Schulz SC. Risperidone in comorbid borderline personality disorder and dysthymia. J Clin Psychopharmacology 1997;17:326-7.
33 Khousam HR, Donnelly NJ. Remission of self-mutilation in a patient with borderline personality during risperidone therapy. J Nerv Ment Disease 1997;195:348-9.
34 Rocca P, Marchiaro L, Cocuzza E, Bogetto F. Treatment of borderline personality disorder with risperidone. J Clin Psychiatry 2002;63:241-4.